Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies159
  • 7D-0.8%
  • 3M3.2%
  • 1Y-21.3%
  • YTD-11.0%

The Healthcare Services industry has stayed flat over the last week. As for the longer term, the industry has declined 21% in the last year. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025US$903.0bUS$2.1tUS$34.7b22x26x0.4x
Wed, 15 Oct 2025US$922.1bUS$2.1tUS$49.3b20.8x18.7x0.4x
Fri, 12 Sep 2025US$889.7bUS$2.1tUS$49.4b21.5x18x0.4x
Sun, 10 Aug 2025US$766.8bUS$2.1tUS$49.1b20.4x15.6x0.4x
Tue, 08 Jul 2025US$859.9bUS$2.1tUS$52.7b21.8x16.3x0.4x
Thu, 05 Jun 2025US$866.4bUS$2.1tUS$52.6b21.4x16.5x0.4x
Sat, 03 May 2025US$912.7bUS$1.7tUS$49.1b23x18.6x0.5x
Mon, 31 Mar 2025US$1.0tUS$1.7tUS$41.5b24.2x24.7x0.6x
Wed, 26 Feb 2025US$966.4bUS$1.7tUS$41.3b24.8x23.4x0.6x
Fri, 24 Jan 2025US$1.1tUS$2.0tUS$41.9b23.9x25.3x0.5x
Sun, 22 Dec 2024US$998.9bUS$2.0tUS$41.4b21.9x24.1x0.5x
Tue, 19 Nov 2024US$1.1tUS$2.0tUS$41.3b25.2x27.5x0.6x
Thu, 17 Oct 2024US$1.2tUS$1.9tUS$43.6b25.4x27.2x0.6x
Sat, 14 Sep 2024US$1.2tUS$1.9tUS$43.3b27.5x28.1x0.6x
Mon, 12 Aug 2024US$1.2tUS$1.9tUS$43.2b28.7x27x0.6x
Wed, 10 Jul 2024US$1.1tUS$1.9tUS$43.4b24.1x24.7x0.6x
Fri, 07 Jun 2024US$1.1tUS$1.9tUS$43.4b26.5x25.5x0.6x
Sun, 05 May 2024US$1.1tUS$1.9tUS$42.3b26.8x25.6x0.6x
Tue, 02 Apr 2024US$1.1tUS$1.8tUS$49.7b25.9x22.9x0.6x
Thu, 29 Feb 2024US$1.1tUS$1.8tUS$50.0b23.8x22.9x0.6x
Sat, 27 Jan 2024US$1.1tUS$1.8tUS$50.0b23.5x22.1x0.6x
Mon, 25 Dec 2023US$1.1tUS$1.8tUS$51.2b23.2x22.4x0.6x
Wed, 22 Nov 2023US$1.1tUS$1.8tUS$51.1b22.1x22.2x0.6x
Fri, 20 Oct 2023US$1.1tUS$1.8tUS$47.1b22.6x24.4x0.6x
Sun, 17 Sep 2023US$1.1tUS$1.8tUS$46.9b21.6x23.2x0.6x
Tue, 15 Aug 2023US$1.1tUS$1.8tUS$46.7b22.6x24.5x0.7x
Thu, 13 Jul 2023US$1.1tUS$1.7tUS$46.1b23.3x22.9x0.6x
Sat, 10 Jun 2023US$1.1tUS$1.7tUS$45.8b22.5x24.4x0.7x
Mon, 08 May 2023US$1.1tUS$1.7tUS$45.7b22.9x24.3x0.6x
Wed, 05 Apr 2023US$1.1tUS$1.4tUS$43.7b22.9x24.6x0.8x
Fri, 03 Mar 2023US$1.1tUS$1.4tUS$44.2b22.1x24.4x0.8x
Sun, 29 Jan 2023US$1.1tUS$1.4tUS$44.8b21x25.1x0.8x
Tue, 27 Dec 2022US$1.2tUS$1.4tUS$44.4b21.4x26.7x0.8x
Thu, 24 Nov 2022US$1.2tUS$1.4tUS$44.4b20.6x26.9x0.8x
Price to Earnings Ratio

26.9x


Total Market Cap: US$1.2tTotal Earnings: US$44.4bTotal Revenue: US$1.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 23.4x202320242025
Current Industry PE
  • Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 26.0x which is higher than its 3-year average PE of 23.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.60x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 7.8% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.39%
Healthcare3.77%
Healthcare Services-0.85%
Healthcare Distributors0.069%
Healthcare Services-0.34%
Managed Healthcare-0.61%
Healthcare Facilities-5.43%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry which is trading above its 3-year average PE ratio of 38.5x.
    • Analysts are expecting annual earnings growth of 16.7%, which is higher than its past year's earnings growth of 13.7% per year.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading below its 3-year average of 21.1x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 29% over the next 5 years.
  • This is better than its past earnings growth rate of 16% per year.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ELV Elevance HealthUS$325.837.3%
+US$4.9b		-18.7%PE13.1x
CI Cigna GroupUS$269.664.5%
+US$3.1b		-16.4%PE11.7x
HCA HCA HealthcareUS$472.652.9%
+US$3.0b		40.7%PE17x
CNC CenteneUS$36.386.2%
+US$1.0b		-38.2%PS0.1x
DGX Quest DiagnosticsUS$186.954.2%
+US$828.8m		16.5%PE21.6x

Latest News

HUM
US$237.12
Humana
7D
-5.9%
1Y
-14.0%

HUM: Confidence Will Increase As Medicare Advantage Star Ratings Recover

Humana's analyst price target has been revised lower by approximately $7 to $288.46. Analysts cite a more cautious outlook on margins and an uneven recovery in Medicare Advantage profitability.
DGX
US$186.95
Quest Diagnostics
7D
4.2%
1Y
16.5%

DGX: Future Revenue Expansion And Partnerships Will Balance Near-Term Risks

Quest Diagnostics saw its analyst price target increase, with several firms now projecting new targets between $195 and $215 per share. Analysts cite strong quarterly results and ongoing positive momentum in core business trends.
ELV
US$325.83
Elevance Health
7D
2.5%
1Y
-18.7%

ELV: Margin Recovery In Government Plans Will Drive Long-Term Upside

Analysts have modestly lowered their price target for Elevance Health, reflecting a shift from $389 to $386. This adjustment takes into account ongoing headwinds related to regulatory-driven membership changes and anticipated pressure in government-sponsored business lines.
CAH
US$205.37
Cardinal Health
7D
0.8%
1Y
72.9%

CAH: Guidance Will Remain Under Scrutiny Amid Industry and Regulatory Pressures

Cardinal Health's analyst price target has been raised from approximately $189 to over $212 per share. Analysts cite strong recent earnings, raised guidance, and continued execution on strategic priorities as key drivers of the upward revision.
LH
US$266.89
Labcorp Holdings
7D
5.6%
1Y
13.5%

LH: Share Repurchases And Expanded Alzheimer’s Testing Will Drive Future Upside

Narrative Update: Labcorp Holdings Analyst Price Target Adjustment Analysts have raised their price target for Labcorp Holdings by $1. This change reflects a marginally improved outlook based on updated fair value and company fundamentals.
BKD
US$10.43
Brookdale Senior Living
7D
10.6%
1Y
99.4%
SGRY
US$15.28
Surgery Partners
7D
-28.9%
1Y
-33.4%
HCA
US$472.65
HCA Healthcare
7D
-0.8%
1Y
37.8%

HCA: Future Performance Will Depend on Supplemental Payment Tailwinds Amid Policy Risks

HCA Healthcare's analyst price target has increased from $471 to approximately $477 per share. Analysts cite strong third-quarter results, sustained supplemental payment tailwinds, and an improved profit margin outlook as key factors behind their more optimistic forecasts.
UNH
US$321.86
UnitedHealth Group
7D
-0.7%
1Y
-45.7%
HIMS
US$36.98
Hims & Hers Health
7D
-9.9%
1Y
91.4%
COR
US$361.94
Cencora
7D
0.3%
1Y
50.7%
CVS
US$77.81
CVS Health
7D
-1.5%
1Y
46.3%

CVS: Earnings Momentum Will Drive Performance as Regulatory Shifts Unfold

Analysts have raised their fair value estimate for CVS Health to $91.52 from $86.20. This adjustment is due to improved earnings visibility and continued momentum following solid quarterly results.
MCK
US$842.09
McKesson
7D
-1.2%
1Y
38.9%
THC
US$192.91
Tenet Healthcare
7D
-6.0%
1Y
24.2%
CI
US$269.66
Cigna Group
7D
1.9%
1Y
-16.1%
HQY
US$101.77
HealthEquity
7D
8.6%
1Y
2.8%